Eli Lilly’s migraine prevention drug Emgality not superior to Pfizer’s Nurtec ODT in head-to-head
In a head-to-head clinical trial, Eli Lilly’s injectable migraine drug Emgality was not superior to the Nurtec ODT tablets out of Pfizer on a primary …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
